JOURNAL CLUB: THE FLUIDS DEBATE. Veronica Ueckermann

Similar documents
Fluids in ICU. JMO teaching 5th July 2016

Fluid Treatments in Sepsis: Meta-Analyses

Managing Patients with Sepsis

Presented by: Indah Dwi Pratiwi

Sepsis Management: Past, Present, and Future

Fluids in Sepsis Less is more. Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth,

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Maria B. ALBUJA-CRUZ, MD ALBUMIN: OVERRATED. Surgical Grand Rounds

Resuscitation fluids in critical care

What is the right fluid to use?

What is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14

Fluid balance in Critical Care

3/14/2017. Pediatric Sepsis: From Goal Directed Therapy to Protocolized Care. Objectives. Developmental Response to Sepsis

Update in Critical Care Medicine

Surgical Resuscitation Management in Poly-Trauma Patients

Fluid resuscitation in specific patient populations: sepsis and traumatic brain injury

Salty Solutions or Salty Problems? Outline. Outline 29/04/2013

Actualités sur le remplissage peropératoire. Philippe Van der Linden MD, PhD

VI.2 ELEMENTS FOR A PUBLIC SUMMARY (VOLUVEN 10%)

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

Comment on infusion solutions containing HES

Fluid Management in the Critically-Ill

Fluids and Lactate. A/Prof Peter Morley

Sepsis: Identification and Management in an Acute Care Setting

Sepsis Management Update 2014

Fluid assessment, monitoring and therapy for the acute nurse

Septic AKI in ICU patients

Intravenous Fluid Therapy in Critical Illness

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

INTRAVENOUS FLUID THERAPY. Tom Heaps Consultant Acute Physician

Impact of Fluids in Children with Acute Lung Injury

John Park, MD Assistant Professor of Medicine

Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale

Steroids in ARDS: if, when, how much? John Fowler, MD, FACEP Dept. of Emergency Medicine Kent Hospital, İzmir, Türkiye

TRAUMA RESUSCITATION. Dr. Carlos Palisi Dr. Nicholas Smith Liverpool Hospital

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London

Acute Kidney Injury for the General Surgeon

Reverse (fluid) resuscitation Should we be doing it? NAHLA IRTIZA ISMAIL

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

Hydroxyethyl starch and bleeding

TACO CASE STUDIES RTC JUNE Kerry Dowling Blood Transfusion Laboratory Manager Jonathan Ricks Blood Transfusion Nurse Practitioner

FLUID RESUSCITATION SUMMARY

Staging Sepsis for the Emergency Department: Physician

Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Salt of the earth or a drop in the ocean An overview of the properties of iv fluids

L : Line and Tube อ นตรายป องก นได จากการให สารน า

Sepsis. National Clinical Guideline Centre. Sepsis: the recognition, diagnosis and management of sepsis. NICE guideline <number> January 2016

Albumina nel paziente critico. Savona 18 aprile 2007

Modern fluid therapy. Anders Perner. Dept of Intensive Care, Rigshospitalet, University of Copenhagen

Fluid Therapy and Outcome: Balance Is Best

Albumin: rationale, use and evidence

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

THe Story of salty Sam

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

1.3.1 SPC, Labelling and Package Leaflet (Voluven Fresenius 6% Solution for Infusion)

Nothing to disclose 9/25/2017

Welcome! While we wait, please open PollEv.com/jhhicu012

9/25/2017. Nothing to disclose

Les solutés de remplissage. Philippe Van der Linden MD, PhD

THE CRITICALLY ILL OLDER PERSON WITH: SEPTIC SHOCK

Albumin Regulation and Reimbursement

J v /A = L p { (P c - P i ) σ (π p - π i ) } 7/13/14. Current Concepts and Controversies in Small Animal Critical Care. Goals and Objec.

Dr. Nai Shun Tsoi Department of Paediatric and Adolescent Medicine Queen Mary Hospital Hong Kong SAR

Fluids Watch the type and measure the quantity

Getting smart with fluids in the critically ill. NOR AZIM MOHD YUNOS Jeffrey Cheah School of Medicine & Health Sciences Monash University Malaysia

Thicker than Water. Alisa McQueen MD, FAAP, FACEP Associate Professor of Pediatrics The University of Chicago

Steroids for ARDS. Clinical Problem. Management

The Use of Metabolic Resuscitation in Sepsis

UTILITY of ScvO 2 and LACTATE

Fluid Management in Critically Ill AKI Patients

Fluid resuscitation in the ICU/sepsis. The use of albumin

How and why I give IV fluid Disclosures SCA Fluids and public health 4/1/15. Andrew Shaw MB FRCA FCCM FFICM

Developed for Scotland by the National Plasma Product Expert Advisory Group. Clinical Guidelines for Human Albumin Use

Updates in Sepsis 2017

Respiratory problems with severe malaria: an opportunity to talk about fluid trials!!! Kathryn Maitland

Developed for Scotland by the National Plasma Product Expert Advisory Group. Clinical Guidelines for Human Albumin Use

Adult Trauma Advances in Pediatrics. (sometimes they are little adults) FAST examination. Who is bleeding? How much and what kind of TXA volume?

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

New Strategies in the Management of Patients with Severe Sepsis

SHOCK and the Trauma Victim. JP Pretorius Department of Surgery & SICU Steve Biko Academic Hospital.

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

Neue Wirkungsmechanismen von Transfusionsplasma

Are Patients Hypoperfused in the ED? Rapid Perfusion Assessment in the Emergency Department

Printed copies of this document may not be up to date, obtain the most recent version from

INTRAVENOUS FLUIDS. Ahmad AL-zu bi

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Michael Avant, M.D. The Children s Hospital of GHS

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

Kristan Staudenmayer, MD Stanford University, Stanford, CA

BREAK 11:10-11:

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

Sepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program

L uso appropriato dell albumina nel trattamento del paziente settico

Fluids and electrolytes: the basics

Transcription:

JOURNAL CLUB: THE FLUIDS DEBATE Veronica Ueckermann

INTRODUCTION The selection and use of resuscitation fluids should be based on physiological principles. However, historically, clinical practice has been determined largely by clinical preference, with marked regional variation. Not just TYPE of resus fluid that determines outcome, but the TIMING and DOSE

OPPOSING STUDIES Got colloids banned VISEP CHEST 6S Brought colloids back CRYSTMAS CRISTAL

VISEP STUDY

CRITICISMS OF VISEP Flawed methodology: Hyperoncotic starch (10%). Prolonged infusions 4 days, 70.4 ml/kg It is known that hyperoncotic colloids impair renal functions and cause renal damage, regardless of the type used ethically flawed

CHEST STUDY

CRITICISM OF CHEST The CHEST study was powered for a single primary endpoint mortality. The result shows clearly that starch solution does not increase mortality, compared to normal saline. More patients who were given HES were given RRT RR confidence interval included one (i.e. not statistically significant) Once data was adjusted for known covariates, the p-value was no longer stastistically significant! Abstract: However, despite a lower overall rate of acute kidney injury, more patients who received resuscitation with HES were given renal replacement therapy

6S STUDY

CRITICISMS OF 6S Study not designed to investigate the secondary endpoint of renal injury: No criteria to initate RRT at discretion of staff in 32 intensive care units RIFLE criteria in fact favour starch group Number of days on dialysis same in both groups Enrollment AFTER resuscitation: Normal values lactate, central venous oxygen saturation at enrolment. Excessive ICU fluid administration: despite adequate resuscitation 4.5 litres of study fluid administered on day 1 and the subsequent 3 days accounts for high mortality in both groups!

FURTHER CONCERNS All 3 studies commenced after resuscitation phase CHEST enrolled on average 11hrs post ICU admission Absence of hypovolemia. In fact majority of the pts studied had already received colloids before randomisation in VISEP, 6S and CHEST! Duration > 24 hours MAINTENANCE with colloids! The largest volume of colloid (80%) administration occurs in trauma and peri-operatively. Yet, the meta-analysis excluded all but one publication in this area. Recent trauma studies suggest that collids is beneficial in resuscitation of trauma patients. FIRST trial saline vs voluven in penetrating trauma Hypotension after spinal anaesthesia: proven benefit colloids, crystalloid preloading ineffective and no longer used. Especially in patients at risk pulmonary oedema (pre-eclampsia)

FURTHER CONCERNS Administration of collids in presence of normal or increased plasma volume damages endothelial glycocalyx with resulatant transudation into the interstitium and worsening coagulopathy. Albumin may be the answer simply too expensive. Remember saline is the way to go for TBI (SAFE trial) Use of blood products as a substitute, in patients without transfusion indications is unsound, taking into account biological risks. Extrapolation from one context to another is DANGEROUS! The designs of these studies ignore basic physiological principles was the problem the colloids or the protocols?

ALL WE REALLY LEARN FROM THESE STUDIES Voluven may cause renal harm in elderly, critically ill patients with sepsis. NO evidence that it should be witheld from non-septic patients who require intravascular volume replacement The taditional ratio of crystalloid to colloids is 1:1.4 not 3:1 traditionally taught

THE STUDY THAT BROUGHT COLLOIDS BACK JAMA. 2013; 310(17):1809-1817.

CRISTAL

CRISTAL

CRISTAL

THE GLYCOCALYX

WHAT WE KNOW ABOUT THE GLYCOCALYX Blood-body-barrier interface between body and blood Components Proteoglycans Glycosaminoglycans Glycoproteins Soluble proteins Functions Gatekeeper determines vascular parmeability and interaction with components of blood Mechanotransduction mechanical protection from shear stress Microenvironment receptor binding, local growth and repair, vasculoprotection

GLYCOCALYX Fluids affect glycocalyx differently (albumin>colloids>crystalloids) Fluid amount influences glycocalyx fx Acute hyperglycemia = loss of glycocalyx volume High LDL levels and high fat diet disrupts glycocalyx Hydrocortisone and ATIII prevent TNF- induced shedding of the glycocalyx Endotoxxemia degreades the pulmonary endothelial glycocalyx and results in neutrophil adhesion in ALI Sepsis and major abdominal surgery damage glycocalyx

THE IDEAL FLUID Produce preodictable and sustained increase in IV volume Chemical composition as close as possible to ECF Metabolised and completely excreted without accumulation in tissues Does not produce adverse metabolic or systemic effects Cost-effective Improves outcomes